KALI PHOS
NDC 15631-2804, KALI PHOS, liquid, from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc.
- Product NDC
- 15631-2804
- Status
- Listed
- Labeler
- Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/15631-2804 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POTASSIUM PHOSPHATE, DIBASIC1 [hp_X]/mL
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 15631-2804-0 | 15631280400 | 10 mL in 1 BOTTLE (15631-2804-0) |
| 15631-2804-1 | 15631280401 | 30 mL in 1 BOTTLE (15631-2804-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 15631-2804 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/15631-2804 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 15631-2804. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.